Search Results - "Chow, Diana S L"

Refine Results
  1. 1
  2. 2

    Characterization of Polymyxin B Biodistribution and Disposition in an Animal Model by Manchandani, Pooja, Zhou, Jian, Ledesma, Kimberly R, Truong, Luan D, Chow, Diana S-L, Eriksen, Jason L, Tam, Vincent H

    Published in Antimicrobial agents and chemotherapy (01-02-2016)
    “…Despite dose-limiting nephrotoxicity concerns, polymyxin B has resurged as the treatment of last resort for multidrug-resistant Gram-negative bacterial…”
    Get full text
    Journal Article
  3. 3

    Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model by He, Jie, Abdelraouf, Kamilia, Ledesma, Kimberly R, Chow, Diana S.-L, Tam, Vincent H

    “…Abstract Polymyxin B (PB) is increasingly used as the last treatment for multidrug-resistant (MDR) Gram-negative bacterial infections. In this study, serum and…”
    Get full text
    Journal Article
  4. 4

    Analytical and functional determination of polymyxin B protein binding in serum by Abodakpi, Henrietta, Gohlke, Jie, Chang, Kai-Tai, Chow, Diana S-L, Tam, Vincent H

    Published in Antimicrobial agents and chemotherapy (01-11-2015)
    “…To enhance our understanding of the pharmacological properties of polymyxin B, serum protein binding for polymyxin B1, B2, and B3 and for isoleucine-polymyxin…”
    Get full text
    Journal Article
  5. 5

    Doxorubicin-loaded hollow gold nanospheres for dual photothermal ablation and chemoembolization therapy by Sheth, Rahul A., Wen, Xiaoxia, Li, Junjie, Melancon, Marites P., Ji, Xin, Andrew Wang, Y., Hsiao, Cheng-Hui, Chow, Diana S.-L., Whitley, Elizabeth M., Li, Chun, Gupta, Sanjay

    Published in Cancer nanotechnology (01-07-2020)
    “…Background Doxorubicin-loaded hollow gold nanospheres (Dox@HAuNS) are a promising technology for simultaneous trans-arterial tumor-targeted chemotherapy…”
    Get full text
    Journal Article
  6. 6

    Pharmacokinetic Basis for Using Saliva Matrine Concentrations as a Clinical Compliance Monitoring in Antitumor B Chemoprevention Trials in Humans by Bui, Dinh, McWilliams, Lenora A, Wu, Lei, Zhou, Haiying, Wong, Stuart J, You, Ming, Chow, Diana S-L, Singh, Rashim, Hu, Ming

    Published in Cancers (23-12-2022)
    “…This study reports the first clinical evidence of significantly high secretion of matrine in a multi-component botanical (Antitumor B, ATB) into human saliva…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetic Variability of Mycophenolic Acid in Pediatric and Adult Patients With Hematopoietic Stem Cell Transplantation by Zhang, Daping, Renbarger, Jamie L., Chow, Diana S-L.

    Published in Journal of clinical pharmacology (01-11-2016)
    “…The aim of this study was to evaluate the pharmacokinetic variations of mycophenolic acid (MPA), the active metabolite of mycophenolate mofetil (MMF), in both…”
    Get full text
    Journal Article
  8. 8

    Development and validation of a highly sensitive LC–MS/MS assay for the quantification of arginine vasopressin in human plasma and urine: Application in preterm neonates and child by Zhang, Daping, Rios, Danielle R., Tam, Vincent H., Chow, Diana S.-L.

    “…•UPLC–MS/MS is highly sensitive for the quantification of arginine vasopressin.•AVP levels determined by UPLC–MS/MS are consistent with the published data.•The…”
    Get full text
    Journal Article
  9. 9

    Simultaneous quantification of mycophenolic acid and its glucuronide metabolites in human plasma by an UPLC-MS/MS assay by Zhang, Daping, Chow, Diana S-L., Renbarger, Jamie L.

    Published in Biomedical chromatography (01-10-2016)
    “…The aim of this study was to develop a reliable UPLC–MS/MS assay for accurate quantification of mycophenolic acid (MPA) and its glucuronide conjugates in human…”
    Get full text
    Journal Article
  10. 10

    Pharmacokinetic Model Analysis of Supralingual, Oral and Intravenous Deliveries of Mycophenolic Acid by Gao, Xiuqing, Wu, Lei, Tsai, Robert Y L, Ma, Jing, Liu, Xiaohua, Chow, Diana S-L, Liang, Dong, Xie, Huan

    Published in Pharmaceutics (17-04-2021)
    “…Mycophenolic acid (MPA) is commonly used for organ rejection prophylaxis via oral administration in the clinic. Recent studies have shown that MPA also has…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Development & validation of LC–MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: Application to pharmacokinetic and oral bioavailability studies by Awosemo, Ololade, Neelakantan, Harshini, Watowich, Stanley, Ma, Jing, Wu, Lei, Chow, Diana S.-L., Liang, Dong

    “…•A simple, specific and reproducible LC–MS/MS assay for 5-AMQ in rat plasma and urine was developed and validated.•The assay was used to characterize…”
    Get full text
    Journal Article
  13. 13

    Longitudinal Impacts of Gastric Bypass Surgery on Pharmacodynamics and Pharmacokinetics of Statins by El-Zailik, Asma, Cheung, Lily K., Wang, Yang, Sherman, Vadim, Chow, Diana S.-L.

    Published in Obesity surgery (01-08-2019)
    “…Purpose Undergoing Roux-en-Y gastric bypass (RYGB) is expected to affect orally administered drug absorption. Statins are commonly prescribed to patients with…”
    Get full text
    Journal Article
  14. 14

    Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury by Wu, Yongchao, Satkunendrarajah, Kajana, Teng, Yang, Chow, Diana S-L, Buttigieg, Josef, Fehlings, Michael G

    Published in Journal of neurotrauma (15-03-2013)
    “…Riluzole, a sodium/glutamate antagonist has shown promise as a neuroprotective agent. It is licensed for amyotrophic lateral sclerosis and is in clinical trial…”
    Get more information
    Journal Article
  15. 15

    Stem Cell Theory of Cancer: Implications for Drug Resistance and Chemosensitivity in Cancer Care by Tu, Shi-Ming, Guo, Charles C, Chow, Diana S-L, Zacharias, Niki M

    Published in Cancers (18-03-2022)
    “…When it concerns cancer care and cancer therapy, drug resistance is more than an obstacle to successful treatment; it is a major cause of frustration in our…”
    Get full text
    Journal Article
  16. 16
  17. 17

    A validated ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of polymyxin B in mouse serum and epithelial lining fluid: application to pharmacokinetic studies by He, Jie, Gao, Song, Hu, Ming, Chow, Diana S-L, Tam, Vincent H

    Published in Journal of antimicrobial chemotherapy (01-05-2013)
    “…A rapid, sensitive and robust ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was developed for the quantification of four…”
    Get full text
    Journal Article
  18. 18

    Clinical Pharmacokinetics of Mycophenolic Acid in Hematopoietic Stem Cell Transplantation Recipients by Zhang, Daping, Chow, Diana S.-L.

    “…Mycophenolate mofetil (MMF), an ester prodrug of mycophenolic acid (MPA), is widely used as a maintenance immunosuppressive regimen in solid organ transplant…”
    Get full text
    Journal Article
  19. 19
  20. 20

    UPLC–MS/MS assay of riluzole in human plasma and cerebrospinal fluid (CSF): Application in samples from spinal cord injured patients by Sarkar, Mahua, Grossman, Robert G., Toups, Elizabeth G., Chow, Diana S.-L.

    “…•Development and validation of UPLC–MS/MS assay of riluzole in human plasma and CSF.•Assay validation as per US FDA Bioanalytical Method Validation: Guidance…”
    Get full text
    Journal Article